7 hours Gilead Sciences (GILD) Stock Dips While Market Gains: Key Facts Zacks

   X     

16 hours Is It Worth Investing in Gilead (GILD) Based on Wall Street’s Bullish Views? Zacks

   X     

6 days GILD vs. ALNY: Which Stock Is the Better Value Option? Zacks

   X     

1 week Why Gilead Sciences (GILD) Outpaced the Stock Market Today Zacks

   X     

1 week Can Gilead Sciences Sustain Its Growth Momentum in 2025? Zacks

   X     

2 weeks The Zacks Analyst Blog Salesforce, Shell and Gilead Sciences Zacks

   X     

2 weeks Top Stock Reports for Salesforce, Shell, Gilead Sciences & Others Zacks

   X     

2 weeks Gilead Sciences (GILD) Rises Yet Lags Behind Market: Some Facts Worth Knowing Zacks

   X     

2 weeks Gilead Sciences, US government settle patent case over HIV prevention drugs Investing.com

   X     

2 weeks Gilead Sciences, US government settle patent case over HIV prevention drugs Yahoo Finance

   X     

2 weeks Final Trade: ANF, GILD YouTube

   X     

2 weeks Gilead Sciences, Inc. (GILD) JPMorgan Annual Healthcare Conference – (Transcript) Seeking Alpha

   X     

2 weeks Drugmakers Just Hiked Prices for Over 500 Medicines Money.com

   X     

2 weeks Gilead CEO on funding for new HIV prevention medicine YouTube

   X     

2 weeks Gilead CEO Daniel O’Day on new HIV prevention medicine: It’s going to change the face of HIV YouTube

   X     

3 weeks Gilead, LEO Pharma partner to develop programs for inflammatory diseases Investing.com

   X     

3 weeks Morgan Stanley upgrades Gilead on HIV treatment growth Investing.com

   X     

3 weeks Gilead Sciences (GILD) Stock Falls Amid Market Uptick: What Investors Need to Know Zacks

   X     

4 weeks Gilead Sciences (GILD) Stock Declines While Market Improves: Some Information for Investors Zacks

   X     

1 month Gilead Sciences: 2025 Preview, A Buy Thanks To Thriving HIV Franchise Seeking Alpha

   X     

1 month Gilead Buys $20.1 Million of Assembly Biosciences Stock Yahoo Finance

   X     

1 month Gilead Sciences, Inc. (GILD) is Attracting Investor Attention: Here is What You Should Know Zacks

   X     

1 month Here’s How You Can Earn $100 In Passive Income By Investing In Gilead Sciences Stock Yahoo Finance

   X     

1 month Gilead Stock Gains 15.4% in a Year: Should You Buy, Sell or Hold? Zacks

   X     

1 month Gilead Sciences (GILD) Gains As Market Dips: What You Should Know Zacks

   X     

1 month GILD’s Trodelvy Gets Second Breakthrough Therapy Tag for Lung Cancer Zacks

   X     

1 month Biotech Stock Roundup: Updates From GILD, REGN, GSK, ANAB Down on Study Data, EWTX Gains Zacks

   X     

1 month Gilead: A Large-Cap Pharma With Limited Patent Cliff Exposure Seeking Alpha

   X     

1 month GILD Obtains Positive CHMP Opinion for Liver Disease Drug Zacks

   X     

1 month Gilead (GILD) Upgraded to Buy: Here’s Why Zacks

   X     

2 months Gilead Sciences (GILD) Stock Moves -0.57%: What You Should Know Zacks

   X     

2 months Gilead appoints Sanofi official Dietmar Berger as next chief medical officer Investing.com

   X     

2 months Is Gilead Sciences (GILD) Stock Undervalued Right Now? Zacks

   X     

2 months Gilead Sciences, Inc. (GILD) Is a Trending Stock: Facts to Know Before Betting on It Zacks

   X     

2 months Final Trade: LMAT, GOOGL, IBM, GILD YouTube

   X     

2 months The Zacks Analyst Blog Highlights Eli Lilly, AbbVie, Gilead Sciences, Air T and Fossil Group Zacks

   X     

2 months Top Stock Reports for Eli Lilly, AbbVie & Gilead Sciences Zacks

   X     

2 months Gilead Sciences Is Turning Itself Around. Why Its Stock Can Keep Rallying. Yahoo Finance

   X     

2 months Gilead Sciences, Inc. (GILD) Annual Evercore ISI HealthCONx Healthcare Conference (Transcript) Seeking Alpha

   X     

2 months Gilead Collaborates With German Biotech Tubulis for Solid Tumor ADC Zacks

   X     

2 months Gilead Sciences, Inc. (GILD) Piper Sandler 36th Annual Healthcare Conference (Transcript) Seeking Alpha

   X     

2 months Is Gilead (GILD) a Buy as Wall Street Analysts Look Optimistic? Zacks

   X     

2 months Gilead Stock Surges 44.2% in 6 Months: Time to Buy or Sell? Zacks

   X     

2 months GILD vs. VRTX: Which Stock Should Value Investors Buy Now? Zacks

   X     

2 months Investors Heavily Search Gilead Sciences, Inc. (GILD): Here is What You Need to Know Zacks

   X     

2 months Gilead Sciences, Inc. (GILD) Jefferies London Healthcare Conference (Transcript) Seeking Alpha

   X     

2 months Market Digest: ADTN, EQR, GILD, NFG, PRU, MSCI Yahoo Finance

   X     

3 months Brokers Suggest Investing in Gilead (GILD): Read This Before Placing a Bet Zacks

   X     

3 months GILD or VRTX: Which Is the Better Value Stock Right Now? Zacks

   X     

3 months Gilead increases 2024 outlook, expects new drug filing by end of year Yahoo Finance

   X     

3 months Gilead Beats on Q3 Earnings and Sales, Raises Annual Outlook Zacks

   X     

3 months Why Gilead’s Solid Q3 Earnings Could Point To A Dividend Surprise Next Year Seeking Alpha

   X     

3 months Gilead Sprints To A Profit-Taking Zone After Riding Covid Drug To Beat And Raise Investor's Business Daily

   X     

3 months Gilead’s third-quarter earnings beat by a wide margin, and biotech raises guidance MarketWatch

   X     

3 months Gilead Science to Report Q3 Earnings: What’s in the Cards? Zacks

   X     

3 months Gilead Sciences (GILD) Gains As Market Dips: What You Should Know Zacks

   X     

3 months Gilead Sciences, Inc. (NASDAQ:GILD) Shares Sold by New York State Teachers Retirement System MarketBeat

   X     

3 months Earnings Preview: Gilead Sciences (GILD) Q3 Earnings Expected to Decline Zacks

   X     

3 months Gilead Sciences (GILD) Stock Sinks As Market Gains: Here’s Why Zacks

   X     

3 months Gilead Sciences (NASDAQ:GILD) Given Sector Perform Rating at Royal Bank of Canada MarketBeat

   X     

3 months Gilead Sciences, Inc. (NASDAQ:GILD) Given Consensus Rating of “Moderate Buy” by Brokerages MarketBeat

   X     

3 months Why Gilead Sciences (GILD) Dipped More Than Broader Market Today Zacks

   X     

3 months Gilead Sciences (NASDAQ:GILD) Sets New 12-Month High – Still a Buy? MarketBeat

   X     

3 months Gilead Sciences (NASDAQ:GILD) Stock Rating Upgraded by Leerink Partnrs MarketBeat

   X     

3 months Gilead, MRK Report Data From Investigational Combination Study for HIV Zacks

   X     

3 months Calls of the Day: Gilead, Berkshire Hathaway and SLB YouTube

   X     

3 months Crew Capital Management Ltd. Makes New Investment in Gilead Sciences, Inc. (NASDAQ:GILD) MarketBeat

   X     

3 months Gilead Sciences (NASDAQ:GILD) Upgraded by Leerink Partners to Outperform MarketBeat

   X     

3 months Stratos Investment Management LLC Lowers Stock Position in Gilead Sciences, Inc. (NASDAQ:GILD) MarketBeat

   X